| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 12/28/2006 | US20060293271 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| 12/28/2006 | US20060293269 oligonucleotide with modified phosphorothioate linkage, sugar moiety, or nucleobase; disease or condition associated with expression of superoxide dismutase 1 |
| 12/28/2006 | US20060293267 Dual functional oligonucleotides for use as anti-viral agents |
| 12/28/2006 | US20060293235 HGF beta chain variants |
| 12/28/2006 | US20060293234 Interaction between MUC1 and beta -catenin can be interrupted using polypeptides or antibodies that specifically bind to the binding site on MUC1, whereby interruption provides the beneficial effect of inhibiting, reducing, and/or retarding invasiveness and metastasis |
| 12/28/2006 | US20060293230 Expression and secretion of icIL-1 receptor antagonist type II |
| 12/28/2006 | US20060292691 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| 12/28/2006 | US20060292678 Gluconobacter oxydans 2-ketoreductase enzyme and applications thereof |
| 12/28/2006 | US20060292674 Nucleotide sequences coding sugar metabolism and oxidative phosphorylation (SMP) protein for preparation and generation of amino acid for use in foods, cosmetics and medicines; bioremediation; terpenoid biosynthesis |
| 12/28/2006 | US20060292672 Cell lines for expressing enzyme useful in the preparation of amidated products |
| 12/28/2006 | US20060292671 utilizes mannitol, arabitol, glucitol, or glycerol to induce expression of a target polypeptide from an inducible promoter, allowing for the use of an inexpensive and stable carbon source inducer in the fermentation processes for the production of recombinant peptides |
| 12/28/2006 | US20060292670 Nell peptide expression systems and bone formation activity of nell peptide |
| 12/28/2006 | US20060292669 Mammalian prickle gene |
| 12/28/2006 | US20060292668 Nuclear factor of activated t cell receptor |
| 12/28/2006 | US20060292667 Method for improving solubility and folding efficiency of target proteins using RNA as molecular chaperone |
| 12/28/2006 | US20060292665 Glutaryl amidases and their uses |
| 12/28/2006 | US20060292643 Recognition molecules for the treatment and detection of tumours |
| 12/28/2006 | US20060292639 Splice variant of the vanilloid receptor VR1A |
| 12/28/2006 | US20060292636 Quantum (TM) phytase; high sensitivity and specificity for the phytase and are useful in immunoassay methods; capable of detecting low concentrations of phytase |
| 12/28/2006 | US20060292629 Chimeric polypeptides and their use |
| 12/28/2006 | US20060292627 PB39, a gene dysregulated in prostate cancer, and uses thereof |
| 12/28/2006 | US20060292625 Novel human leucine-rich repeat domain containing protein HLLRCR-1 |
| 12/28/2006 | US20060292620 Genes with ES cell-specific expression |
| 12/28/2006 | US20060292613 Methods and compounds for prevention and treatment of elevated intraocular pressure and related conditions |
| 12/28/2006 | US20060292609 Interferon-beta gene therapy using an improved, regulated expression system |
| 12/28/2006 | US20060292608 Using fluorescent profiles to reveal variation in genic copy number in cells; diagnosing cell proliferative disorders |
| 12/28/2006 | US20060292602 diagnosing the syndrome in a human female subject comprising by pyrosequencing bi-allelic single nucleotide polymorphisms (SNPs) using informative primers; quick, efficient, accurate and early detection |
| 12/28/2006 | US20060292598 Nucleotide sequences coding mitogenic racemase for use diagnostic probe in detection and prevention of parasite infection; immunotherapy |
| 12/28/2006 | US20060292596 Cloning, sequencing and expression of a gene encoding an eukaryotic amino acid racemase, and diagnostic, therapeutic, and vaccination applications of parasite and viral mitogens |
| 12/28/2006 | US20060292593 Nucleotide sequences coding B7 immune response regulatory protein selectively expressed on dendritic cells for use as therapeutic tool in targeting viral and tumor cell for destruction |
| 12/28/2006 | US20060292592 Incubation in presence of nucleobase, hybridization |
| 12/28/2006 | US20060292591 Genes from the 20q13 amplicon and their uses |
| 12/28/2006 | US20060292590 NOD nucleic acids and polypeptides |
| 12/28/2006 | US20060292589 Oligonucleotide probes containing two labels useful in hybridization assays |
| 12/28/2006 | US20060292587 Polynucleotides encoding insect voltage-gated chloride channel and uses thereof |
| 12/28/2006 | US20060292581 Biosensor for small molecule analytes |
| 12/28/2006 | US20060292580 Cleavage of nucleic acids |
| 12/28/2006 | US20060292579 Methods of enzymatic discrimination enhancement and surface bound double-stranded DNA |
| 12/28/2006 | US20060292578 Nucleotide sequences coding thermus filiformis heat resistant transferase with reduced exonuclease activity; for use in DNA sequencing, nucleic acid amplification, cDNA and nucleic synthesis |
| 12/28/2006 | US20060292577 Neoplasia-specific splice variants and methods |
| 12/28/2006 | US20060292573 Human orthologues of WART |
| 12/28/2006 | US20060292568 Method of preparing dna fragments and applications thereof |
| 12/28/2006 | US20060292567 Method and means for determining specific conditions or changes in the uterine epithelium and in the epithelium of other organs |
| 12/28/2006 | US20060292563 Methods of diagnosing & treating diabetes and insulin resistance |
| 12/28/2006 | US20060292557 contacting a biological sample suspected of containing anti-herpes simplex virus type-2 (HSV-2) antibodies with an antigen comprising a nonapeptide and with a second antigen capable of binding specific anti-HSV-2 antibody, to detect the presence or absence of a specific anti-HSV-2 antibody |
| 12/28/2006 | US20060292551 cationic peptides useful in the treatment of dermatitis and viral infections; for topical administration |
| 12/28/2006 | US20060292546 Herg channel-expressing cell |
| 12/28/2006 | US20060292178 Proteins encoded by the severe acute respiratory syndrome (SARS) coronavirus and a role in apoptosis |
| 12/28/2006 | US20060292168 Methylated heparin-binding hemagglutinin recombinant mycobacterial antigen, preparation method and immunogenic compositions comprising same |
| 12/28/2006 | US20060292161 Protective epitopes of adenyl cyclase-haemolysin (AC-Hly), their application to the treatment or to the prevention of bordetella infections |
| 12/28/2006 | US20060292157 MDA-7 protein variants having antiproliferative activity |
| 12/28/2006 | US20060292154 A34 and a33-Like 3dna, proteins, antibodies thereto and methods of treatment using same |
| 12/28/2006 | US20060292153 Polypeptides, polynucleotides encoding same, antibodies thereagainst and methods of using same for diagnosing and treating cancer and skeletal disorders |
| 12/28/2006 | US20060292152 used for the for the medical diagnosis and treatment of Alzheimer's disease |
| 12/28/2006 | US20060292146 Isolated PTPMT1 protein which mediates insulin production and uses thereof |
| 12/28/2006 | US20060292144 Human disintegrin protein |
| 12/28/2006 | US20060292143 Novel T-cell membrane protein (TIRC7), peptides and antibodies derived therefrom and uses thereof |
| 12/28/2006 | US20060292140 Humanized immunoglobulin reactive with alpha4beta7 integrin |
| 12/28/2006 | US20060292138 Fusion proteins comprising an allergen sequence linked via an IgG hinge region to another polypeptide sequence capable of specifically binding to a native IgG inhibitory receptor containing an immune receptor tyrosine based inhibitory motif |
| 12/28/2006 | US20060292130 2-O sulfatase nucleic acid compositions |
| 12/28/2006 | US20060292120 COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF ANGIOGENESIS |
| 12/28/2006 | CA2850323A1 Methods and compositions involving mirna and mirna inhibitor molecules |
| 12/28/2006 | CA2612859A1 Coagulation factor iii polymorphisms associated with prediction of subject outcome and response to therapy |
| 12/28/2006 | CA2612389A1 Genemap of the human genes associated with longevity |
| 12/28/2006 | CA2611877A1 Synthetic gene control region |
| 12/28/2006 | CA2611743A1 Nucleic acid analysis by random mixtures of non-overlapping fragments |
| 12/28/2006 | CA2610861A1 Normalization of samples for amplification reactions |
| 12/28/2006 | CA2587189A1 Methods and compositions involving mirna and mirna inhibitor molecules |
| 12/28/2006 | CA2582661A1 Compositions and methods for detecting group a streptococci |
| 12/27/2006 | EP1736552A1 Nucleolipids and their use and apparatus for nucleic acid anaylsis |
| 12/27/2006 | EP1736501A1 Peg-functional nucleic acid conjugate |
| 12/27/2006 | EP1736479A2 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 12/27/2006 | EP1735695A2 Integrated configuration system for use in a process plant |
| 12/27/2006 | EP1735443A2 RNA INTERFERENCE MEDIATED TREATMENT OF POLYGLUTAMINE (POLYQ) REPEAT EXPANSION DISEASES USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 12/27/2006 | EP1735338A2 Anthrax antigens and methods of use |
| 12/27/2006 | EP1735329A2 Novel carotenoid hydroxylases for use in engineering carotenoid metabolism in plants |
| 12/27/2006 | EP1735328A1 Protein c and endothelial protein c receptor polymorphisms as indicators of subject outcome |
| 12/27/2006 | EP1735011A2 Method of modulating vascularization |
| 12/27/2006 | EP1734991A2 Compositions with modified nucleases targeted to viral nucleic acids and methods of use for prevention and treatment of viral diseases |
| 12/27/2006 | EP1734979A2 Follicle stimulating hormone superagonists |
| 12/27/2006 | EP1734811A2 Use of interfering rna in the production of transgenic animals |
| 12/27/2006 | EP1684789A4 Mammalian t1r3 sweet taste receptors |
| 12/27/2006 | EP1631578A4 Recombinant plant dicer |
| 12/27/2006 | EP1507873A4 Parallel stranded duplexes of deoxyribonucleic acid and methods of use |
| 12/27/2006 | EP1368500B1 Method for preparative production of long nucleic acids by pcr |
| 12/27/2006 | EP1123386B1 Method for producing chiral carboxylic acids from nitriles with the assistance of a nitrilase or microorganisms which contain a gene for the nitrilase |
| 12/27/2006 | CN1886520A Primers and a screening method for identification of artemisinin producing plants |
| 12/27/2006 | CN1886500A Phosphokinase and the usage thereof |
| 12/27/2006 | CN1886424A Anti-IGF-I receptor antibody |
| 12/27/2006 | CN1886420A Self-assembling split-fluorescent protein systems |
| 12/27/2006 | CN1886417A HIV-dependent expression constructs and uses therefor |
| 12/27/2006 | CN1886148A Selective inhibition of NF-kB activation by peptides designed to disrupt NEMO oligomerization |
| 12/27/2006 | CN1886042A Coordinated decrease and increase of gene expression of more than one gene using transgenic constructs |
| 12/27/2006 | CN1884529A DNA molecular marking method for researching fish genetic relation |
| 12/27/2006 | CN1884526A RNA interference method for specificly and high effectively treating CSFV infection and biological formulation |
| 12/27/2006 | CN1884525A Method for obtaining plant introne sequence amplification polymorphism and its special primer |
| 12/27/2006 | CN1884296A Marker primer linked with wheat powdery mildew resistant gene Pm6 and its usage method |
| 12/27/2006 | CN1884295A Oxygen deficient induction factor1 antisense oligonucleotide and its uses |
| 12/27/2006 | CN1292254C Kit for inspecting infection of swine pleuropneumonia actinomyces |
| 12/27/2006 | CN1292066C Gene related to human lung canceration |